RUSSIA-UKRAINE WAR Reports: Pope may meet Russian patriarch in Jerusalem, discuss Russia-Ukraine war
The pope has called for an Easter truce in Ukraine
The Pope, who is scheduled to visit Lebanon and Jordan in June, might also stop in Jerusalem to speak with Russian Orthodox Patriarch Kirill, who has heavily supported Moscow in the war against Ukraine.
Reuters reported that two sources said the Vatican is "studying the possibility of extending Pope Francis' trip" to include Jerusalem.
Kirill termed the war a "special military operation" in Ukraine.
"Let the Lord help us unite during this difficult time for our Fatherland, including around the authorities," Kirill was quoted as saying at a sermon in Moscow, according to the Interfax news agency.
On the other hand, Francis has called it a war, using words such as invasion, aggression and atrocities. He also called for an Easter truce in Ukraine, as did Franklin Graham, president of Samaritan's Purse – an Evangelical humanitarian aid outreach currently operating in Ukraine.
Popular article:
interview Easter message of resurrection hope amid war at Jerusalem's Garden Tomb
biblical commentary Let my people go: a Passover message for today
4 IDF soldiers killed, 2 wounded in fighting in southern Lebanon, as Israel eliminates dozens of Hezbollah terrorists
Receive latest news & updates
A message from All Israel News
Help us educate Christians on a daily basis about what is happening in Israel & the Middle East and why it matters.
For as little as $10, you can support ALL ISRAEL NEWS, a non-profit media organization that is supported by readers like you.
Latest articles:
1969 Dutch Eurovision winner Lenny Kuhr moves to Israel – cites antisemitism, family ties
Israel bars French far-left leader Mélenchon in response to France's entry ban on settlement leader
Change Bloc divided over coalition with Arab or ultra-Orthodox parties after week of negotiations
Huckabee fires back as Senate Democrats target US-Israel intelligence ties: 'Shocking!'
Israeli blood test detects early breast cancer with 95% accuracy, assesses recurrence risk